HIV - 2/14 - Xconomy

Entry	Author	Date	Location
Gilead Pursues Cancer, Inflammation as Next Step To Diversify Beyond HIV	Luke Timmerman	02/23/11	San Francisco
Calistoga Hands the Keys to Gilead, Bets It Can Make Cancer a Chronic Disease Like HIV	Luke Timmerman	02/23/11	Seattle
Gilead Buys Calistoga Pharma for $375M, Making Move Into Cancer Drugs	Luke Timmerman	02/22/11	Seattle
Quanterix, Novartis Test Out Super-Sensitive Diagnostic Tool for Neuro Disorder	Luke Timmerman	02/22/11	Boston
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections	Luke Timmerman	01/18/11	Seattle
State Awards Global Health Grants	Luke Timmerman	01/12/11	Seattle
Genzyme Initiates Job Cuts, Dana-Farber/Gatekeeper Suit Advances, GTC Bought by LFB, & More Boston-Area Life Sciences News	Erin Kutz	11/12/10	Boston
EMC Acquisitions Could Include Isilon, LFB Buys GTC, Tremor Media Snaps Up ScanScout, & More Boston-Area Deals News	Erin Kutz	11/10/10	Boston
Daktari Brings In $1.8M	Erin Kutz	11/05/10	Boston
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News	Erin Kutz	11/05/10	Boston
ChemoCentryx, Pursuing the Dream For Autoimmune Disease, Seeks to Put a Pill in a Bottle	Luke Timmerman	11/04/10	San Francisco
$20M Series A For Karyopharm to Fight Cancer	Erin Kutz	11/03/10	Boston
Dana Farber Gets $33M from Sanofi, Astellas Backs DecImmune, Ironwood Sells Microbia, & More Boston-Area Deals News	Erin Kutz	09/29/10	Boston
Genentech Inks Antibody Deal, Cytokinetics Sticks With Science First, BioMarin Scraps Drug, & More Bay Area Life Sciences News	Luke Timmerman	08/06/10	San Francisco
Dendreon Shows Provenge Demand, Seattle Genetics Inks Big Deal, Corey Gets Top Hutch Job, & More Seattle-Area Life Sciences News	Luke Timmerman	08/05/10	Seattle
Larry Corey, Virus Hunter With Midwest Roots, Seeks to Unleash Health Innovation at Hutch	Luke Timmerman	08/02/10	Seattle
Gates Foundation’s Tachi Yamada: Biotechies and VCs are Missing Out on Global Health	Luke Timmerman	07/30/10	Seattle
LS9 Reveals Key Biofuel Genes, Onyx Drug Passes Big Trial, Solazyme Seeks First-Mover Edge, & More Bay Area Life Sciences News	Luke Timmerman	07/30/10	San Francisco
Gilead Borrowing $2.2B	Luke Timmerman	07/26/10	San Francisco
Concert Pharma Riding Potential $1B Glaxo Deal, Looks Ahead to Human Data on HIV Drug	Ryan McBride	07/14/10	Boston
Accelerator, Taking a Break from Curing Cancer, Unwinds With Some Mini-Golf Hijinks	Luke Timmerman	07/12/10	Seattle
Jackpot Scores $14M, MIT Startup Wins 20K-Euro Prize, Nuance Acquires ShapeWriter, & More Boston-Area Deals News	Erin Kutz	06/23/10	Boston
Gilead CF Drug Passes Trial	Luke Timmerman	06/18/10	San Francisco
Curis Misses Mark in Cancer Drug Trial, Genzyme Re-Elects Full Board, GTC Cuts Jobs, & More Boston-Area Life Sciences News	Erin Kutz	06/18/10	Boston
Daktari Diagnostics, Backed by Gates Foundation, Raises Funds for HIV Test Study	Ryan McBride	06/17/10	Boston
Theraclone Sciences CEO David Fanning Dies Suddenly	Luke Timmerman	06/14/10	Seattle
Dendritic Nanotechnologies Focuses Dendrimer Development On Industry Rather Than Pharma	Howard Lovy	05/07/10	Detroit
Averting “Disaster” in Healthcare: Xconomy Forum at MIT Tackles Big Problems and Potential Technology Fixes	Ryan McBride	04/28/10	Boston
Technology Alliance Showcases Five Companies in Sensors, Mobile Displays, and Drug Therapies: Investors Take Notice	Gregory T. Huang	04/22/10	Seattle
Anadys Reports Interim Hep C Drug Data, Ligand Collects Milestone Payment, Phenomix’s Diabetes Drug Shows Promise, & More San Diego Life Sciences News	Denise Gellene	04/22/10	San Diego
Page 2 of 5	« previous page · next page »

Entry

Author

Date

Location

Gilead Pursues Cancer, Inflammation as Next Step To Diversify Beyond HIV

Luke Timmerman

02/23/11

San Francisco

Calistoga Hands the Keys to Gilead, Bets It Can Make Cancer a Chronic Disease Like HIV

Luke Timmerman

02/23/11

Seattle